On May 29, the U.S. Food and Drug Administration (FDA) warned consumers and healthcare professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. The FDA found that the counterfeit contains the wrong active ingredients. Read more

FDA warns against counterfeit Adderall

New needle-free jet injection device offers improvement over similar devices

FDA approves Levaquin for plague

A 200-year perspective on hospital costs and mortality

Marriage may promote happiness

Joint Commission issues new requirements for health and wellness programs

Analysis: Good communication enhances patient safety, satisfaction

CMS broadens ‘medical staff’ concept to include APRNs

Physician supports APRNs in Atlantic article

Distance education offers a wealth of formats and options

It’s all in the translation

Better sleep: Antidote to on-the-job fatigue

Exercising on the go

This Special Report has been funded by BD Medical

Taking action to prevent bloodborne infections

Bloodborne infection from sharps and mucocutaneous exposure: A continuing problem

Additional resources on bloodborne infection

Spotlight on safety: Preventing pathogen exposure on the job

Navigating organizational politics

Civility starts with you

How to put on a successful CE conference

Pooling the power of goodness to create change

In praise of nursing residency programs

Demystifying ventricular arrhythmias

Asthmatic teenager lands in the ICU

Environment, health, & safety

Issues up close

Headlines from the Hill

From Your ANA President

Transcatheter aortic valve replacement: New hope for patients with aortic stenosis

Understanding psychogenic nonepileptic seizures

Healthy and wise

Doing the right thing: Pathways to moral courage

Wulf H. Utian MD, PhD, DSc

MY OBJECTIVES AND WHO I AM

Will the Supreme Court back the U.S. into a one-payer system?